Targeting ryanodine receptors with allopurinol and xanthine derivatives for the treatment of cardiac and musculoskeletal weakness disorders
Proceedings of the National Academy of Sciences, Volume 122, Issue 24, June 2025. SignificanceCardiac and skeletal muscle weakness are serious